ANTIVIRAL RESEARCH
Scope & Guideline
Pioneering Insights in Viral Therapeutics
Introduction
Aims and Scopes
- Antiviral Drug Development:
Research dedicated to the identification and characterization of new antiviral agents, including small molecules, monoclonal antibodies, and vaccines, aimed at various viral infections. - Viral Pathogenesis and Immunology:
Investigation into the mechanisms of viral replication, host interactions, and immune responses to viral infections, providing insights that inform therapeutic strategies. - Vaccine Research and Development:
Studies focused on the design, efficacy, and safety of vaccines against viral pathogens, including innovative delivery systems and adjuvants. - Genetic and Molecular Virology:
Research on the genetic and molecular basis of viral pathogenesis, including studies on viral genome structure, replication mechanisms, and resistance to antiviral agents. - Clinical Research and Epidemiology:
Studies that evaluate the clinical outcomes of antiviral treatments and the epidemiology of viral infections, providing data to guide public health interventions. - Emerging and Re-emerging Viral Infections:
Research targeting newly identified viruses and variants, emphasizing the importance of surveillance and rapid response to emerging viral threats.
Trending and Emerging
- COVID-19 and SARS-CoV-2 Research:
A surge in studies related to SARS-CoV-2, including vaccine development, therapeutic interventions, and understanding viral mutations, has become a dominant theme following the pandemic. - Host-Directed Therapies:
Research on targeting host factors to inhibit viral replication is emerging as a promising strategy, showcasing the potential of host-directed antiviral therapies. - mRNA Technology in Antiviral Vaccines:
The success of mRNA vaccines against COVID-19 has sparked interest in using mRNA technology for other viral infections, leading to innovative vaccine designs. - Broad-Spectrum Antivirals:
Increased focus on developing agents that can target multiple viruses or viral families, driven by the need for preparedness against future pandemics. - Nanotechnology in Antiviral Applications:
Emerging use of nanotechnology for drug delivery systems and vaccine platforms is gaining traction, enhancing the efficacy and reach of antiviral therapies. - Artificial Intelligence in Drug Discovery:
The application of AI and machine learning in identifying potential antiviral agents and understanding viral-host interactions is becoming increasingly prevalent.
Declining or Waning
- Traditional Antiviral Agents:
Research on older antiviral drugs has diminished, as the field shifts focus towards novel therapeutics and combination therapies that address resistance issues. - Non-specific Immunomodulators:
Interest in broad-spectrum non-specific immunomodulatory agents appears to be waning, with a greater emphasis placed on targeted therapies and precision medicine approaches. - In vitro Studies with Limited Clinical Relevance:
There is a noticeable reduction in studies that rely solely on in vitro models without clear translational applications, as the field increasingly values research that bridges laboratory findings with clinical outcomes. - Viral Resistance Mechanisms:
While still important, the frequency of publications specifically focused on mechanisms of resistance in established antiviral therapies has decreased, potentially reflecting advancements in understanding and addressing these issues.
Similar Journals
ACTA VIROLOGICA
Exploring the evolving landscape of infectious diseases.ACTA VIROLOGICA, a key journal in the field of virology and infectious diseases, is published by FRONTIERS MEDIA SA in Slovakia, serving the global scientific community with groundbreaking research since its inception in 1957. This esteemed journal, identified by ISSN 0001-723X and E-ISSN 1336-2305, provides a platform for rigorous peer-reviewed articles that contribute significantly to our understanding of viral pathogens and their implications in medicine. Positioned within the Q3 category for both Infectious Diseases and Miscellaneous Medicine, and a Q4 category for Virology in 2023, ACTA VIROLOGICA offers crucial insights into the evolving landscape of virology research. With its robust accessibility options, this journal appeals to a diverse readership, including researchers, healthcare professionals, and students, fostering a collaborative environment to advance the field of virology. The editorial objective is to enhance the catalog of knowledge pertaining to viruses, promoting innovative approaches in prevention, diagnostics, and treatment. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND, ACTA VIROLOGICA continues to be a vital resource in the collective efforts to combat viral disease challenges.
VIRUS GENES
Exploring the Genetic Blueprint of VirusesVIRUS GENES is an esteemed journal published by Springer, dedicated to advancing our understanding of virology and its related fields, including genetics, molecular biology, and immunology. With a publication history that spans from 1987 to 2024, this journal provides researchers and professionals with a platform to disseminate high-quality, peer-reviewed articles that explore the intricacies of viral genetics and their implications in health and disease. With an impact factor placing it in the Q3 quartile across multiple categories in 2023, including Genetics and Virology, VIRUS GENES serves as a crucial resource for academics seeking to stay at the forefront of viral research. Its commitment to showcasing innovative research makes it an invaluable asset for students and professionals aiming to deepen their knowledge in the rapidly evolving landscape of virology. Although currently not offering Open Access, the journal ensures wide accessibility through institutional subscriptions, thereby playing a vital role in the collaboration between scientists globally.
Journal of Virus Eradication
Leading the charge in infectious disease research.Welcome to the Journal of Virus Eradication, a premier publication dedicated to advancing the field of virology and infectious disease research. Published by MEDISCRIPT LTD, this journal provides a vital platform for sharing cutting-edge research findings in key areas including epidemiology, immunology, and public health. With an impressive classification of Q2 in Epidemiology and Infectious Diseases for 2023, this journal exemplifies a commitment to high-quality scholarship and impactful research. The Journal of Virus Eradication is instrumental in disseminating knowledge that tackles viral threats, contributing to global health initiatives aimed at virus containment and eradication. Researchers, professionals, and students alike will find this journal an invaluable resource, making significant contributions to the scientific community and society at large.
REVIEWS IN MEDICAL VIROLOGY
Catalyzing Research in Antiviral TherapeuticsREVIEWS IN MEDICAL VIROLOGY is a premier academic journal published by Wiley, dedicated to advancing the field of virology and infectious diseases. Established in 1991, this journal has gained a reputable standing, holding a Q1 ranking in both Infectious Diseases and Virology as of 2023, with impressive Scopus rankings placing it at #17 out of 344 in the realm of Medicine - Infectious Diseases, and #8 out of 80 in Immunology and Microbiology - Virology. This reflects its substantial impact factor and contribution to ongoing research and scholarship. While it is not an Open Access publication, REVIEWS IN MEDICAL VIROLOGY offers vital insights and comprehensive reviews that cater to a diverse audience including researchers, healthcare professionals, and students pursuing knowledge in medical virology. The journal serves as a vital resource for understanding the complexities of viral pathogens and the evolving landscape of antiviral therapeutics, making it an essential read for those poised at the forefront of infectious disease research.
Annual Review of Virology
Advancing virology through comprehensive insights.Annual Review of Virology is a premier scholarly journal published by Annual Reviews, dedicated to advancing the field of virology through comprehensive and insightful reviews. Since its inception in 2014, this journal has established itself as a leading resource for researchers, professionals, and students alike, achieving an impressive Q1 ranking in the field of Virology and a Scopus rank of #10 out of 80 in its category, placing it in the 88th percentile. The journal features in-depth analyses of the latest developments in virology, encompassing various aspects such as viral pathogenesis, host interactions, and antiviral strategies, thereby catering to a diverse audience seeking the most relevant and cutting-edge information. Although it is not Open Access, Annual Review of Virology remains an indispensable tool for those engaged in virology research, transforming complex findings into accessible knowledge that shapes future investigations and practical applications in the field.
Frontiers in Virology
Shaping the Future of Virology Through CollaborationFrontiers in Virology, published by FRONTIERS MEDIA SA, is an innovative open-access journal dedicated to advancing the understanding of viral biology, pathogenesis, surveillance, and control strategies. With the rapid evolution of viral threats, this journal serves as a critical platform for researchers, professionals, and students to disseminate and access high-quality research, reviews, and perspectives in virology. The journal places a strong emphasis on interdisciplinary approaches, promoting collaborative efforts that drive breakthroughs in the field. While the specific impact factor and H-index details are currently unavailable, Frontiers in Virology is committed to rigorous peer review and integrity in scientific publishing. Authors and readers will benefit from the extensive reach provided by open access, making groundbreaking insights available to a global audience, thus contributing significantly to the ongoing dialogue in virology and public health.
ANTIVIRAL THERAPY
Advancing the frontier of antiviral research.ANTIVIRAL THERAPY is a prominent academic journal dedicated to the field of infectious diseases and pharmacology, published by SAGE Publications Ltd in the United Kingdom. Since its inception in 1996, this journal has become an essential platform for disseminating cutting-edge research and innovative therapeutic approaches for viral infections, making significant contributions to advancements in medical science. With an HIndex indicating the quality and influence of its published work, ANTIVIRAL THERAPY holds prestigious rankings in its categories, including Q3 in Infectious Diseases and Pharmacology as of 2023. While it currently does not offer open access, the journal provides valuable insights that are crucial for researchers, healthcare professionals, and students engaged in antiviral research and treatment strategies. As it converges towards 2024, the journal continues to play a vital role in shaping the understanding and management of viral diseases, making it a critical resource for anyone involved in this important field of study.
VIROLOGIE
Illuminating the pathogenesis and epidemiology of viruses.VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.
Hepatitis Monthly
Unveiling breakthroughs in hepatitis management.Hepatitis Monthly, published by BRIEFLAND in the Netherlands, is a pivotal journal in the fields of hepatology and infectious diseases. Established in 2007, it continues to make significant contributions to the understanding and management of hepatitis and related viral infections with a publication timeline extending through to 2024. Aiming to disseminate high-quality research, the journal serves as a forum for groundbreaking studies and innovations essential for healthcare professionals, researchers, and students alike. While it currently holds Q4 rankings in both hepatology and infectious disease categories, its ongoing commitment to addressing pressing health issues makes it an important resource in the academic community. Although it operates under a traditional access model, Hepatitis Monthly not only publishes original research articles, reviews, and case studies but also encourages the exchange of knowledge that helps shape future research directions and clinical practices. As it continues to explore the complexities surrounding viral hepatitis, this journal invites researchers to contribute to its mission of advancing scientific understanding and improving patient care.
JOURNAL OF VIROLOGICAL METHODS
Bridging gaps in virology through advanced research methods.Journal of Virological Methods, published by Elsevier, is a prominent peer-reviewed journal dedicated to advancing the methodologies employed in virology research. Since its inception in 1980, this esteemed journal has become a vital resource for researchers, professionals, and students focused on the intricate study of viruses and viral-related diseases. With a current ISSN of 0166-0934 and an E-ISSN of 1879-0984, this journal strives to present innovative techniques and tools that enhance our understanding of virology. Designed for a global audience, it operates in a rigorous academic environment, as reflected by its 2023 Scopus ranking of #40 in the Virology category and its Q3 quartile placement. The journal is committed to fostering open dialogue and collaboration within the scientific community, ultimately contributing to the development of novel strategies and interventions against viral infections. By offering comprehensive insights into virological methodologies, the Journal of Virological Methods continuously serves as a cornerstone for those dedicated to exploring the complexities of viral research.